Radiat Environ Biophys 2004, 43:77–84.PubMedCrossRef 25. Nias AH: Radiation and platinum drug interaction. Int J Radiat Biol Related Stud Phys, Chem Med 1985, 48:297–314.CrossRef 26. Elleaume H, Rousseau J, Barth RF, Fernandez M, Adam JF, Esteve F: Response to Dr. Nicholas Foray’s commentary on the paper by Rousseau et al. find more entitled “”Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors”". J Neuro-Oncol 2011, 101:165–167.CrossRef 27. Guarnieri M, Carson BS, Khan A, Penno M, Jallo selleck chemicals GI: Flexible versus rigid catheters for chronic administration of exogenous agents into central nervous system tissues. J Neurosci Methods 2005, 144:147–152.PubMedCrossRef

28. Khan A, Jallo GI, Liu YJ, Carson BS Sr, Guarnieri M: Infusion rates and drug distribution in brain tumor models in rats. J Neurosurg 2005, 102:53–58.PubMed 29. Corde S, Balosso J, Elleaume H, Renier M, Joubert A, Biston MC, Adam JF,

Charvet AM, Brochard T, Le Bas JF, et al.: Synchrotron photoactivation MAPK inhibitor of cisplatin elicits an extra number of DNA breaks that stimulate RAD51-mediated repair pathways. Cancer Res 2003, 63:3221–3227.PubMed 30. Adam JF, Elleaume H, Joubert A, Biston MC, Charvet AM, Balosso J, Le Bas JF, Esteve F: Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: first trial on rats bearing F98 gliomas. Int J Radiat Oncol Biol Phys 2003, 57:1413–1426.PubMedCrossRef 31. Adam JF, Joubert A, Biston MC, Charvet AM, Peoc’h M, Le Bas JF, Balosso J, Esteve F, Elleaume H: Prolonged survival of Fischer rats bearing F98

glioma after iodine-enhanced synchrotron stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 2006, 64:603–611.PubMedCrossRef 32. Corde S, Joubert A, Adam JF, Charvet AM, Le Bas JF, Esteve F, Elleaume H, Balosso J: Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds. Br J Cancer 2004, 91:544–551.PubMedCrossRef 33. Taupin F, Bobyk L, Delorme R, Ravanat JL, Elleaume H: Anti-canceral therapy by gold nanoparticle photoactivation. Bulletin Du Cancer 98:80. 34. Cho SH, Jones BL, Krishnan S: The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) Elongation factor 2 kinase via brachytherapy using low-energy gamma-/x-ray sources. Phys Med Biol 2009, 54:4889–4905.PubMedCrossRef 35. McMahon SJ, Mendenhall MH, Jain S, Currell F: Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles. Phys Med Biol 2008, 53:5635–5651.PubMedCrossRef 36. Kobayashi K, Usami N, Porcel E, Lacombe S, Le Sech C: Enhancement of radiation effect by heavy elements. Mutat Res 704:123–131. 37. Yang WL, Huo TY, Barth RF, Gupta N, Weldon M, Grecula JC, Ross BD, Hoff BA, Chou TC, Rousseau J, Elleaume H: Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors.